This study is for adults with type 2 diabetes (T2D), who haven't been able to control their blood sugar well with metformin, a common diabetes medicine. The goal is to compare two drugs: orforglipron and dapagliflozin, to see which helps more in managing blood sugar levels. The study will last about 46 weeks, which is a little less than a year. People who join will need to have a certain blood sugar level and be taking a stable dose of metformin. They also need to keep their weight steady without starting a new diet or exercise program.

• The study lasts about 46 weeks.
• Participants should keep their weight steady.
• They will be comparing two medicines for managing blood sugar.

Some people cannot join, like those with Type 1 diabetes (T1D) or certain other health conditions. This study will help find the best treatment for people with T2D who need better blood sugar control.